Medifast, Inc.
MED
$13.40
$0.211.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 480.45M | 543.45M | 602.46M | 674.48M | 770.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 480.45M | 543.45M | 602.46M | 674.48M | 770.18M |
| Cost of Revenue | 125.67M | 141.88M | 157.84M | 176.70M | 200.71M |
| Gross Profit | 354.78M | 401.58M | 444.62M | 497.77M | 569.48M |
| SG&A Expenses | 349.80M | 403.40M | 437.24M | 482.53M | 530.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 479.96M | 549.78M | 599.58M | 663.63M | 735.93M |
| Operating Income | 487.00K | -6.32M | 2.88M | 10.85M | 34.25M |
| Income Before Tax | 6.25M | -7.27M | 3.79M | 12.32M | 37.29M |
| Income Tax Expenses | 2.62M | -275.00K | 1.70M | 4.99M | 7.96M |
| Earnings from Continuing Operations | 3.64 | -7.00 | 2.09 | 7.33 | 29.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.64M | -7.00M | 2.09M | 7.33M | 29.33M |
| EBIT | 487.00K | -6.32M | 2.88M | 10.85M | 34.25M |
| EBITDA | 20.30M | 12.51M | 21.69M | 20.64M | 47.34M |
| EPS Basic | 0.33 | -0.64 | 0.19 | 0.67 | 2.69 |
| Normalized Basic EPS | 0.36 | -0.42 | 0.22 | 0.71 | 2.14 |
| EPS Diluted | 0.32 | -0.65 | 0.18 | 0.66 | 2.68 |
| Normalized Diluted EPS | 0.36 | -0.42 | 0.21 | 0.70 | 2.13 |
| Average Basic Shares Outstanding | 43.81M | 43.76M | 43.72M | 43.68M | 43.63M |
| Average Diluted Shares Outstanding | 43.96M | 43.84M | 43.85M | 43.80M | 43.76M |
| Dividend Per Share | -- | -- | -- | 0.00 | 1.65 |
| Payout Ratio | 5.39% | -2.84% | 34.18% | 255.16% | 125.26% |